{"id":"https://openalex.org/W2108965461","doi":"https://doi.org/10.1158/1078-0432.ccr-10-1994","title":"Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models","display_name":"Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models","publication_year":2010,"publication_date":"2010-11-09","ids":{"openalex":"https://openalex.org/W2108965461","doi":"https://doi.org/10.1158/1078-0432.ccr-10-1994","mag":"2108965461","pmid":"https://pubmed.ncbi.nlm.nih.gov/21062934"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-10-1994","doi":"https://doi.org/10.1158/1078-0432.ccr-10-1994","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-10-1994","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109602009","display_name":"Ansgar Santel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ansgar Santel","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082712473","display_name":"Manuela Aleku","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Manuela Aleku","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084963987","display_name":"Nadine R\u00f6der","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nadine R\u00f6der","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025325301","display_name":"Kristin M\u00f6pert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kristin M\u00f6pert","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018894898","display_name":"Birgit Durieux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Birgit Durieux","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037670747","display_name":"Oliver Janke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Oliver Janke","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028553670","display_name":"Oliver Keil","orcid":"https://orcid.org/0000-0003-1503-4812","observed_orcids":["https://orcid.org/0000-0003-1503-4812"]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Oliver Keil","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073503336","display_name":"Jens Endruschat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Endruschat","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070000495","display_name":"Sibylle Dames","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sibylle Dames","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101436003","display_name":"Christian M. Lange","orcid":"https://orcid.org/0000-0002-7582-0076","observed_orcids":["https://orcid.org/0000-0002-7582-0076"]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Lange","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040519331","display_name":"Mona Eisermann","orcid":"https://orcid.org/0000-0001-6764-2751","observed_orcids":["https://orcid.org/0000-0001-6764-2751"]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Mona Eisermann","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013167848","display_name":"Kathrin L\u00f6ffler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kathrin L\u00f6ffler","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062594557","display_name":"Melanie Fechtner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Melanie Fechtner","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087047675","display_name":"Gerald Fisch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerald Fisch","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070676459","display_name":"Christiane Vank","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christiane Vank","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069533118","display_name":"Ute Schaeper","orcid":"https://orcid.org/0000-0003-2556-8391","observed_orcids":["https://orcid.org/0000-0003-2556-8391"]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ute Schaeper","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081242986","display_name":"Klaus Giese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Klaus Giese","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066283050","display_name":"J\u00f6rg Kaufmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102048","display_name":"Silence Therapeutics (Germany)","ror":"https://ror.org/01hwrdv70","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210102048","https://openalex.org/I4210134646"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J\u00f6rg Kaufmann","raw_affiliation_strings":["Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Silence Therapeutics AG, Berlin, Germany","institution_ids":["https://openalex.org/I4210102048"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210102048"],"apc_list":null,"apc_paid":null,"fwci":3.1233,"has_fulltext":false,"cited_by_count":107,"citation_normalized_percentile":{"value":0.92859606,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"16","issue":"22","first_page":"5469","last_page":"5480"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.6234999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.6234999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13437","display_name":"Mechanisms of cancer metastasis","score":0.14790000021457672,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0778999999165535,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.5950000286102295},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.8399999737739563},{"id":"https://openalex.org/keywords/hematogenous-metastasis","display_name":"hematogenous metastasis","score":0.9210000038146973},{"id":"https://openalex.org/keywords/ve-cadherin","display_name":"VE-cadherin","score":0.921999990940094},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.578000009059906},{"id":"https://openalex.org/keywords/lewis-lung-carcinoma","display_name":"Lewis lung carcinoma","score":0.7170000076293945},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.765999972820282},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.8399999737739563},{"id":"https://openalex.org/keywords/mda-mb-435","display_name":"MDA-MB-435","score":0.9390000104904175},{"id":"https://openalex.org/keywords/mammary-fat-pad","display_name":"mammary fat pad","score":0.7429999709129333},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.7429999709129333},{"id":"https://openalex.org/keywords/micrometastasis","display_name":"micrometastases","score":0.8899999856948853},{"id":"https://openalex.org/keywords/metastasis-prevention","display_name":"metastasis prevention","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.837321400642395},{"id":"https://openalex.org/C2778123414","wikidata":"https://www.wikidata.org/wiki/Q2779635","display_name":"Micrometastasis","level":4,"score":0.8043549060821533},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6914255619049072},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.5769063234329224},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5384381413459778},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5219632983207703},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4947752356529236},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.48417121171951294},{"id":"https://openalex.org/C2777847059","wikidata":"https://www.wikidata.org/wiki/Q6537255","display_name":"Lewis lung carcinoma","level":4,"score":0.4147162139415741},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20516788959503174}],"mesh":[{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D018827","descriptor_name":"Carcinoma, Lewis Lung","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D018827","descriptor_name":"Carcinoma, Lewis Lung","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034622","descriptor_name":"RNA Interference","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-10-1994","doi":"https://doi.org/10.1158/1078-0432.ccr-10-1994","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-10-1994","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:21062934","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21062934","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321114","display_name":"Bundesministerium f\u00fcr Bildung und Forschung","ror":"https://ror.org/04pz7b180"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1518520618","https://openalex.org/W1520425169","https://openalex.org/W1963655153","https://openalex.org/W1964146045","https://openalex.org/W1967600348","https://openalex.org/W1969328947","https://openalex.org/W1972759067","https://openalex.org/W1975216289","https://openalex.org/W1976527118","https://openalex.org/W1982474356","https://openalex.org/W1982902233","https://openalex.org/W1984085632","https://openalex.org/W1985850338","https://openalex.org/W2001583023","https://openalex.org/W2012247886","https://openalex.org/W2015714994","https://openalex.org/W2017322644","https://openalex.org/W2022233074","https://openalex.org/W2034713890","https://openalex.org/W2037943855","https://openalex.org/W2043166238","https://openalex.org/W2045467626","https://openalex.org/W2045562838","https://openalex.org/W2047887335","https://openalex.org/W2057533148","https://openalex.org/W2057711788","https://openalex.org/W2058598294","https://openalex.org/W2062265555","https://openalex.org/W2066834504","https://openalex.org/W2070396671","https://openalex.org/W2076489703","https://openalex.org/W2089370460","https://openalex.org/W2110643890","https://openalex.org/W2111605241","https://openalex.org/W2111792559","https://openalex.org/W2125386114","https://openalex.org/W2126088749","https://openalex.org/W2136023563","https://openalex.org/W2149162919","https://openalex.org/W2151637779","https://openalex.org/W2154358347"],"related_works":["https://openalex.org/W2314850910","https://openalex.org/W2262639129","https://openalex.org/W2953810786","https://openalex.org/W1982902233","https://openalex.org/W2568538505","https://openalex.org/W2055237396","https://openalex.org/W1999040411","https://openalex.org/W2039708666","https://openalex.org/W4234130440","https://openalex.org/W2387315382"],"abstract_inverted_index":{"PURPOSE:":[0],"Atu027,":[1],"a":[2,194,219],"novel":[3],"RNA":[4,59],"interference":[5],"therapeutic,":[6],"has":[7],"been":[8],"shown":[9],"to":[10,27,38,94,129,237],"inhibit":[11],"lymph":[12],"node":[13],"metastasis":[14,37,67,75,106,159,225,234],"in":[15,34,43,63,120,140,163,172,189,207,235],"orthotopic":[16],"prostate":[17],"cancer":[18,239],"mouse":[19,47,76],"models.":[20,48],"The":[21],"aim":[22],"of":[23,32,138,142,148,156,197],"this":[24],"study":[25],"is":[26],"elucidate":[28],"the":[29,39],"pharmacologic":[30],"activity":[31],"Atu027":[33,51,99,149,214],"inhibiting":[35],"hematogenous":[36,233],"target":[40,199],"organ":[41],"lung":[42,66,70,105,158,224],"four":[44],"different":[45],"preclinical":[46],"EXPERIMENTAL":[49],"DESIGN:":[50],"compared":[52],"with":[53,165,174],"vehicle":[54],"or":[55],"control":[56],"small":[57],"interfering":[58],"lipoplexes":[60],"was":[61,160],"tested":[62],"two":[64],"experimental":[65],"models":[68,77],"(Lewis":[69],"carcinoma,":[71],"B16V)":[72],"and":[73,104,109,115,210],"spontaneous":[74,157],"(MDA-MB-435,":[78],"MDA-MB-231,":[79],"mammary":[80,177],"fat":[81,178],"pad).":[82],"Different":[83],"dosing":[84],"schedules":[85],"(repeated":[86],"low":[87],"volume":[88],"tail":[89],"vein":[90,123],"injections)":[91],"were":[92,107,111,126],"applied":[93],"obtain":[95],"insight":[96,132],"into":[97,133],"effective":[98],"treatment.":[100],"Primary":[101],"tumor":[102,167],"growth":[103],"measured,":[108],"tissues":[110],"analyzed":[112],"by":[113],"immunohistochemistry":[114],"histology.":[116],"In":[117,153,181],"vitro":[118],"studies":[119],"human":[121],"umbilical":[122],"endothelial":[124,204],"cells":[125],"carried":[127],"out":[128],"provide":[130,184],"an":[131,187],"molecular":[134],"changes":[135],"on":[136],"depletion":[137],"PKN3,":[139],"support":[141],"efficacy":[143],"results.":[144],"RESULTS:":[145],"Intravenous":[146],"administration":[147],"prevents":[150],"pulmonary":[151],"metastasis.":[152],"particular,":[154],"formation":[155],"significantly":[161],"inhibited":[162],"animals":[164],"large":[166],"grafts":[168],"as":[169,171,193,218],"well":[170],"mice":[173],"resected":[175],"primary":[176],"pad":[179],"tumors.":[180],"addition,":[182],"we":[183],"evidence":[185],"that":[186],"increase":[188],"VE-cadherin":[190],"protein":[191],"levels":[192],"downstream":[195],"result":[196],"PKN3":[198],"gene":[200],"inhibition":[201],"may":[202],"change":[203],"function,":[205],"resulting":[206],"reduced":[208],"colonization":[209],"micrometastasis":[211],"formation.":[212],"CONCLUSION:":[213],"can":[215],"be":[216,229],"considered":[217],"potent":[220],"drug":[221],"for":[222,231],"preventing":[223,232],"formation,":[226],"which":[227],"might":[228],"suitable":[230],"addition":[236],"standard":[238],"therapy.":[240]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}